Holding(s) in Company

RNS Number : 1227J
Deltex Medical Group PLC
24 March 2010
 



 


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:

Deltex Medical Group plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:

Gartmore Investment Limited    

4. Full name of shareholder(s)
 (if different from 3.):

See attached schedule

5. Date of the transaction and date on
which the threshold is crossed or
reached:

22nd March 2010

6. Date on which issuer notified:

23rd March 2010

7. Threshold(s) that is/are crossed or
reached:

11%



 

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0059337583

12,821,111

 

12,821,111

 

14,003,111

 


14,003,111


11.034%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

-

-

-

-

-


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

 

% of voting rights

 

-

-

-

-

 

-

Nominal

Delta

-

-


Total (A+B+C)

Number of voting rights

Percentage of voting rights

 

14,003,111

 

11.034%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

n/a


Proxy Voting:

10. Name of the proxy holder:

n/a

11. Number of voting rights proxy holder will cease
to hold:

n/a

12. Date on which proxy holder will cease to hold
voting rights:

n/a



13. Additional information:

All figures are based on the Company's issued share capital of 126,914,336 as provided by Exshare

 

E mail contact RDU@Gartmore.com

14. Contact name:

RDU

15. Contact telephone number:

     0207 782 2324

  

 

 

Share Description

Fund managing Co.

Shares held

% of Issues Share Capital

UK Registered Owner

Beneficial Owner

Equities

DELTEX MEDICAL GRP

ORD GBP0.01

Gartmore Fund

Managers Limited

 

 

Gartmore

Investment Limited

 

 

 

6,562,815

 

 

 

1,132,000

 

6,308,296

 

 

 

 

5.171%

 

 

 

0.892%

 

4.971%

 

 

 

HSBC GLOBAL CUSTODY NOMINEE UK LTD

 

NORTRUST NOMINEES LIMITED

VIDACOS NOMINEES LTD A/C 2303

 

 

 

GARTMORE FUND MANAGERS LTD A/C GARTMORE UK & IRISH SMALLER COMPANIES

 

STRATHCLYDE PENSION FUND

 

THE ALPHAGEN VOLANTIS FUND LIMITED


14,003,111

11.034%









14,003,111

11.034%



 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEALDLASEEEFF
UK 100

Latest directors dealings